A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Columbia University Medical Center - Nephrology, New York

Jacobi Medical Center, The Bronx

Northeast Clinical Research Center, LLC, Bethlehem

Mendez Center for Clinical Research LLC, Fairfax Station

Physician's East Endocrine Research, Greenville

Kidney Care Augusta, Augusta

South Florida Research Institute, Lauderdale Lakes

Gulfcoast Endocrine and Diabetes Center, Clearwater

Coastal Nephrology Associates, Port Charlotte

University of Alabama Birmingham, Birmingham

Nephrology Associates, Chattanooga

Four Rivers Clinical Research, Inc, Paducah

Remington-Davis Clinical Research, Columbus

Research By Design, Evergreen Park

Washington University School of Medicine, St Louis

Clinical Research Consultants, LLC, Kansas City

University of Kansas Medical Center, Kansas City

Northwest Louisiana Nephrology, Shreveport

Renal Disease Research Intitute, Dallas

Renal Associates, PA, San Antonio

Research Management, Inc., Austin

Denver Nephrology, Denver

Boise Kidney & Hypertension, PLLC, Caldwell

Boise Kidney & Hypertension, PLLC, Meridian

Advanced Clinical Research, West Jordan

Phoenician Centers for Research & Innovation (PCRI), Phoenix

University of California Los Angeles, Los Angeles

Larry Stonesifer, M.D., Federal Way

Tufts Medical Center - Division of Nephrology Tufts Medical Center, Boston

The Warren Alpert School of Brown University, Providence